Arturo Ciccullo

39PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsGene and molecular therapyBehavioural epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort.

|Feb 05, 2025
Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir.

Pierluigi Francesco Salvo, Arturo Ciccullo, Elena Visconti

|Dec 19, 2024
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.

R A Passerotto, F Lamanna, P F Salvo

|Oct 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.

Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo

|Oct 29, 2024
Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.

Arturo Ciccullo, Valentina Iannone, Damiano Farinacci

|Apr 29, 2024
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.

Alberto Borghetti, Arturo Ciccullo, Francesca Lombardi

Pageof 7

Frequent Collaborators

13 joint publications

Gianmaria Baldin

11 joint publications

Alberto Borghetti

7 joint publications

Damiano Farinacci

5 joint publications

Gaetana Sterrantino